TTR and Alzheimer disease: Because BBB breakdown has been shown to be an early biomarker of human cognitive dysfunction33 and blood TTR levels could be a possible marker of blood-to-CSF barrier disruption31, the dynamic changes of plasma TTR, a transporter protein associated with the permeability of BBB, may reflect the dysfunction of BBB in AD during the different disease stages.